Sort
50,496 grants matching “lung cancer”
Cell Production Core Facility
$1,172,145Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Surgery Branch Cell Prep Core
$1,172,143John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
National Black Leadership Initiative on Cancer III: Community Network
$1,171,704Daniel Blumenthal · Morehouse School Of Medicine · U01 · FY2008 · CA
Georgia NCI Community Oncology Research Program (NCORP)
$1,170,828Guilherme Cantuaria · Northside Hospital Atlanta · UG1 · FY2015 · CA
Georgia NCI Community Oncology Research Program (NCORP)
$1,170,828Guilherme Cantuaria · Northside Hospital Atlanta · UG1 · FY2014 · CA
Helicobacter pylori Pathogenesis Studies
$1,170,657Kevin Gardner · National Institute On Minority Health And Health Disparities · ZIA · FY2015 · MD
Genetic Epidemiology of Cancer
$1,170,631Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2022 · HG
Genetic Analysis of Drosophila Functional Aging
$1,170,293Rolf Bodmer · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2015 · AG
Novel Targets for Immunotherapy
$1,170,238Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
INTEGRATED CENTER FOR IN VIVO MICROSCOPY
$1,169,658George Allan Johnson · Duke University · P41 · FY2017 · EB
Molecular Pathology of Pulmonary Carcinogenesis
$1,169,604Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Rotating PET and linear accelerator system for PET-guided radiation therapy
$1,169,548Samuel Mazin · Reflexion Medical, Inc. · R44 · FY2014 · CA
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells
$1,169,414Phillip A. Dennis · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Development of Akt Inhibitors
$1,169,414Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Determining the Fate of Transmembrane Proteins
$1,169,176Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
RAND-UCLA CanCORS PDCR Application
$1,168,707Rand Corporation · U01 · FY2005 · CA
INHIBITION OF CARCINOGENESIS BY TEA AND TEA CONSTITUENTS
$1,168,439Rutgers The St Univ Of Nj New Brunswick · P01 · FY2004 · CA
Cancer Immunotherapy Clinical Trials
$1,168,320Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Hematopathology Diagnosis
$1,167,470Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$1,167,374Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
$1,165,750Kristy Perez · Civatech Oncology, Inc. · R44 · FY2018 · CA
PET Enabled Y-90 Microspheres for Radioembolization of Liver Tumors
$1,165,716Yongren Benjamin Peng · Xl Sci-Tech, Inc. · R44 · FY2022 · CA
Cell Prep Core
$1,165,478John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Cell Production Core Facility
$1,165,478Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
DF/HCC Renal Cancer SPORE
$1,165,299Michael B Atkins · Beth Israel Deaconess Medical Center · P50 · FY2008 · CA